gliclazide has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, M; Park, PH; Song, K; Sun, Y | 1 |
| Cai, J; Guo, H; Huang, M; Jing, Y; Li, K; Liu, D; Luan, S; Ma, T; Yang, J; Zhao, L; Zhou, D | 1 |
| Cui, TX; Huang, M; Jin, SY; Li, K; Liu, D; Zhao, LX | 1 |
| Bosland, MC; Chen, A; Dakshinamoorthy, G; Gnanasekar, M; Kajdacsy-Balla, A; Samykutty, A; Shetty, AV; Thirugnanam, S; Zheng, G | 1 |
4 other study(ies) available for gliclazide and Cancer of Prostate
| Article | Year |
|---|---|
Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells.
Topics: Androgen Antagonists; Antineoplastic Agents; Cell Death; Cell Proliferation; Drug Screening Assays, Antitumor; Glycyrrhetinic Acid; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Tumor Cells, Cultured | 2020 |
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Glycyrrhetinic Acid; Humans; Imidazoles; Male; Molecular Conformation; NIMA-Interacting Peptidylprolyl Isomerase; Propionates; Prostatic Neoplasms; Structure-Activity Relationship | 2017 |
[Design, synthesis and antiproliferative activity in cancer cells of novel 18β-glycyrrhetinic acid derivatives].
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Glycyrrhetinic Acid; HL-60 Cells; Humans; Male; Prostatic Neoplasms | 2015 |
18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Prostatic Neoplasms; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2011 |